TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06074861 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05161026 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06443996 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03968913 — Safety Biomarker (SAF): Interleukin 1
Study NCT04683562 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT04683562 — Safety Biomarker (SAF): Netrin-1
Genes: NTN1; NTN1L
Study NCT05582876 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06103409 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04987268 — Predictive Biomarker (PRD): STUB1 mRNA
Genes: STUB1; CHIP; PP1131
Study NCT04828460 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06655415 — Predictive Biomarker (PRD): ACAD8 mRNA
Genes: ACAD8; ARC42; IBD
Study NCT05249699 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT06558136 — Predictive Biomarker (PRD): TNFSF14 mRNA
Genes: TNFSF14; HVEML; LIGHT; UNQ391/PRO726
Study NCT06558136 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06558136 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT06558136 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT05709509 — Predictive Biomarker (PRD): CYBB mRNA
Genes: CYBB; NOX2
Study NCT05709509 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05709509 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT04933695 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04933695 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT04933695 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06680882 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT05734495 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05734495 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT06025643 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04835519 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT06693271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05456243 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05371522 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT05079009 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04746222 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study NCT06747728 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06746870 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06746870 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06746870 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06746870 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06746870 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04753307 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05576961 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05345860 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04811859 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT06224257 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT06164483 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study NCT04868578 — Predictive Biomarker (PRD): ABCC6 mRNA
Genes: ABCC6; ARA; MRP6
Study NCT05340374 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06303921 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT06481839 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06191640 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06358417 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06293131 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06022601 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06092034 — Predictive Biomarker (PRD): LAMP2 mRNA
Genes: LAMP2
Study NCT04662723 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04662723 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04702893 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04483973 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05528458 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02547675 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02547675 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03712657 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT04216121 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04766814 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT05822843 — Predictive Biomarker (PRD): TNFRSF13C mRNA
Genes: TNFRSF13C; BAFFR; BR3
Study NCT02586831 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04537143 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06309186 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04759508 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05670054 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05670054 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04122105 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT04976595 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06450158 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06680713 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06209437 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05626816 — Predictive Biomarker (PRD): GNS mRNA
Genes: GNS
Study NCT05390931 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00098163 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00000842 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT05023707 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04708379 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05059912 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT04948515 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT05788276 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05788276 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06210464 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT06210464 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study NCT06023004 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06334458 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT04697290 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06312956 — Predictive Biomarker (PRD): TRAPPC9 mRNA
Genes: TRAPPC9; KIAA1882; NIBP; T1
Study NCT05043675 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study NCT06134960 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT06134960 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT05262881 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT05262881 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05262881 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT04510194 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05850351 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05297201 — Predictive Biomarker (PRD): PDE10A mRNA
Genes: PDE10A
Study NCT04819971 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05143021 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05325632 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05514574 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04801745 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT04815278 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04263831 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05984381 — Predictive Biomarker (PRD): COL17A1 mRNA
Genes: COL17A1; BP180; BPAG2
Study NCT04543838 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04067752 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04067752 — Safety Biomarker (SAF): Interleukin 1
Study NCT06681298 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05376449 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05376449 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05323786 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04796545 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06064266 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04992936 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04992936 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06402331 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04886804 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04768075 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00015652 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05504889 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05504889 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT05530655 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06549738 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study NCT06280287 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04963712 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05754684 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05754684 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05821400 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05821400 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT05821400 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06000722 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04757246 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04340908 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03228940 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT05034562 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04727593 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04727593 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04727593 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04727593 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04548037 — Predictive Biomarker (PRD): CA1 mRNA
Genes: CA1
Study NCT06247566 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT06340516 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05124535 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06353854 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05986383 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05394168 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT05585957 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05585957 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04687384 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05657925 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05815173 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06624436 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06624436 — Predictive Biomarker (PRD): IL1RN mRNA
Genes: IL1RN; IL1F3; IL1RA
Study NCT05777954 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06306612 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06306612 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT06099925 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT05944211 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study NCT06319768 — Predictive Biomarker (PRD): TFG mRNA
Genes: TFG
Study NCT06319768 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06319768 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05679518 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study NCT05180006 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study NCT05180006 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05780073 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05661110 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05661110 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05085366 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05266105 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05266105 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05266105 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05266105 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05720260 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04824950 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06364475 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06465095 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT06465095 — Predictive Biomarker (PRD): AIM2 mRNA
Genes: AIM2
Study NCT06465095 — Predictive Biomarker (PRD): IFI16 mRNA
Genes: IFI16; IFNGIP1
Study NCT05531266 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT05531266 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05556239 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06414603 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06382116 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05490407 — Predictive Biomarker (PRD): ATP7A mRNA
Genes: ATP7A; MC1; MNK
Study NCT05751044 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT06557096 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04823182 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06259123 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05523401 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study NCT05210907 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06441448 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04879758 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04826523 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05998993 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04695847 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT04695847 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04695847 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06611566 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06612580 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05639751 — Predictive Biomarker (PRD): SMARCA2 mRNA
Genes: SMARCA2; BAF190B; BRM; SNF2A; SNF2L2
Study NCT05644769 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04619927 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04515394 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04515394 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04515394 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06589674 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06250283 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00000909 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00000909 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03955679 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT00001090 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06041464 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06037018 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05856188 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT06691217 — Predictive Biomarker (PRD): TET2 mRNA
Genes: TET2; KIAA1546; Nbla00191
Study NCT06692803 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03866954 — Predictive Biomarker (PRD): TYMP mRNA
Genes: TYMP; ECGF1
Study NCT06747195 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT05875701 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05295758 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05118217 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06746233 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT04254861 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT04188665 — Predictive Biomarker (PRD): PDPN mRNA
Genes: PDPN; GP36; PSEC0003; PSEC0025
Study NCT04971421 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT04971421 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05017324 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study NCT04254289 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05639634 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05654779 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT05244993 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06111053 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT04655508 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05818293 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05818293 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04790851 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04790851 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04741711 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05196048 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04949139 — Surrogate Endpoint (SUR): Serum sodium
Study NCT05032118 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05916196 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT05916196 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05106387 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06045780 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT06045780 — Predictive Biomarker (PRD): CREB3 mRNA
Genes: CREB3; LZIP
Study NCT05425030 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05472753 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06535425 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05327426 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05743218 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05507944 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT06400303 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04712656 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05283577 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05283577 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05283577 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT00002168 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05150236 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27